Effects of melatonin on the proliferation and differentiation of rat adipose-derived stem cells

ABSTRACT

Background: Osteogenesis driven by adipose-derived stem cells (ADSCs) is regulated by physiological and pathological factors. Accumulating evidence from in vitro and in vivo experiments suggests that melatonin may have an influence on bone formation. However, little is known about the effects of melatonin on osteogenesis, which thus remains to be elucidated. This study was performed to determine whether melatonin at physiological concentrations (0.01-10 nM) could affect the in vitro proliferation and osteogenic differentiation of rat ADSCs.Materials and Methods: ADSCs were isolated from the fat of adult rats. After cell expansion in culture media and through three passages, osteogenesis was induced in a monolayer culture using osteogenic medium with or without melatonin at physiological concentrations (0.01-10 nM). After four weeks, the cultures were examined for mineralization by Alizarin Red S and von Kossa staining and for alkaline phosphatase (ALP) activity using an ALP kit. Cell viability and apoptosis were also assayed by 3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTT) assay and flow cytometry, respectively.Results: The results indicated that at physiological concentrations, melatonin suppressed proliferation and differentiation of ADSCs. These data indicate that ADSCs exposed to melatonin, had a lower ALP activity in contrast to the cells exposed to osteogenic medium alone. Similarly, mineral deposition (calcium level) also decreased in the presence of melatonin. Flow cytometry confirmed that cell growth had decreased and that the numbers of apoptotic cells had increased.Conclusion: These results suggest that the physiological concentration of melatonin has a negative effect on ADSC osteogenesis.

KEYWORDS

adipose tissue - differentiation - melatonin - osteogenic - stem cells

• 1 Huang JI, Beanes SR, Zhu M, Lorenz HP, Hedrick MH, Benhaim P. Rat extramedullary adipose tissue as a source of osteochondrogenic progenitor cells. Plast Reconstr Surg 2002; 109: 1033-41
• 2 Hattori H, Masuoka K, Sato M, Ishihara M, Asazuma T, Takase B. etal. Bone formation using human adipose tissue-derived stromal cells and a biodegradable scaffold. J Biomed Mater Res 2006; 76: 230-9
• 3 Caplan AL. Review: Mesenchymal stem cells: Cell-based reconstructive therapy in orthopedics. Tissue Eng 2005; 11: 1198-211
• 4 Auquier P, Macquart-Moulin G, Moatti JP, Blache JL, Novakovitch G, Blaise D. et al. Comparison of anxiety, pain and discomfort in two procedures of hematopoietic stem cell collection: Leukacytapheresis and bone marrow harvest. Bone Marrow Transplant 1995; 16: 541-7
• 5 Auquier P, Macquart-Moulin G, Moatti JP, Blache JL, Novakovitch G, Blaise D. et al. Comparison of anxiety and pain in two procedures of hematopoietic stem cell collection: Cytapheresis and bone marrow collection. Bull Cancer 1995; 82: 582-8
• 6 Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD. et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7
• 7 Nishimori M, Yamada Y, Hoshi K, Akiyama Y, Hoshi Y, Morishima Y. et al. Health related quality of life of unrelated bone marrow donors in Japan. Blood 2002; 99: 1995-2001
• 8 Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H. et al. Human adipose tissue is a source of multipotent stem cells. Moll Biol Cell 2002; 13: 4279-95
• 9 Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ. et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001; 7: 211-28
• 10 Nathan S, Das De S, Thambyah A, Fen C, Goh J, Lee EH. Cell-based therapy in the repair of osteochondral defects: A novel use for adipose tissue. Tissue Eng 2003; 9: 733-44
• 11 Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 1997; 64: 295-312
• 12 Halvorsen YD, Franklin D, Bond AL, Hitt DC, Auchter C, Boskey AL. et al. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng 2001; 7: 729-41
• 13 Satomura K, Tobiume S, Tokuyama R, Yamasaki Y, Kudoh K, Maeda E. et al. Melatonin at pharmacological doses enhances human osteoblastic differentiation in vitro and promotes mouse cortical bone formation in vivo. J Pineal Res 2007; 42: 231-9
• 14 Sainz RM, Mayo JC, Rodriguez C, Tan DX, Lopez-Burillo S, Reiter RJ. Melatonin and cell death: Differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci 2003; 60: 1407-26
• 15 Roth JA, Kim BG, Lin WL, Cho MI. Melatonin promotes osteoblast differentiation and bone formation. J Biol Chem 1999; 274: 22041-7
• 16 Moreau A, Wang DS, Forget S, Azeddine B, Angeloni D, Fraschini F. et al. Melatonin signaling dysfunction in adolescent idiopathic scoliosis. Spine 2004; 29: 1772-81
• 17 Gregory CA, Gunn WG, Peister A, Prockop DJ. An Alizarin red-based assay of mineralization by adherent cells in culture: Comparison with cetylpyridinium chloride extraction. Anal Biochem 2004; 329: 77-84
• 18 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54
• 19 Merklein F, Hendrich C, Kochinki G, Rader CP, Schütze N. et al. Standardized tests of bone implant surfaces with an osteoblast cell culture system [Orthopedic standard materials]. Biomed Tech (Berl) 1998; 43: 354-9
• 20 Luchetti F, Canonico B, Mannello F, Masoni C, D′Emilio A, Battistelli M. et al. Melatonin prevents apoptosis induced by UV-B treatment in U937 cell line. J Pineal Res 2006; 40: 158-67
• 21 Chucharoen P, Chetsawang B, Putthaprasart C, Srikiatkhachorn A, Govitrapong P. The presence of melatonin receptors and inhibitory effect of melatonin on hydrogen peroxide-induced endothelial nitric oxide synthase expression in bovine cerebral blood vessels. J Pineal Res 2007; 43: 35-41
• 22 Melatonin Karasek M.. human aging and age-related diseases. Exp Gerontol 2004; 39: 1723-9
• 23 Zwirska-Korczala K, Jochem J, Adamczyk-Sowa M, Sowa P, Polaniak R, Birkner E. et al. Influence of melatonin on cell proliferation, antioxidative enzyme activities and lipid peroxidation in 3T3-L1 preadipocytes: An in vitro study. J Physiol Pharmacol 2005; 56 S 91-9
• 24 Moriya T, Horie N, Mitome M, Shinohara K. Melatonin influences the proliferative and differentiative activity of neural stem cells. J Pineal Res 2007; 42: 411-8
• 25 Roth JA, Rosenblatt T, Lis A, Bucelli R. Melatonin-indced suppression of PC12 cell growth is mediated by its Gi coupled transmembrane receptors. Brain Res 2001; 16 919: 139-46
• 26 Slominisky A, Pruski D. Melatonin inhibit proliferation and melanogenesis in rodent melanoma cells. Exp Cell Res 1993; 206: 189-94
• 27 Roth JA, Rabin R, Agnello K. Melatonin suppression of PC12 cell growth and death. Brain Res 1997; 768: 63-70